A detailed history of Ameritas Investment Partners, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 14,760 shares of MRNA stock, worth $1.75 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,760
Previous 14,880 0.81%
Holding current value
$1.75 Million
Previous $1.48 Million 6.29%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $10,244 - $13,852
-120 Reduced 0.81%
14,760 $1.57 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $29,333 - $44,069
422 Added 2.92%
14,880 $1.48 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $201,978 - $265,247
2,095 Added 16.95%
14,458 $1.49 Million
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $14,786 - $21,475
109 Added 0.89%
12,363 $1.9 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $78,130 - $138,626
-660 Reduced 5.11%
12,254 $2.2 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $31,524 - $51,846
-267 Reduced 2.03%
12,914 $1.53 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $32,445 - $48,915
-277 Reduced 2.06%
13,181 $1.88 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $15,681 - $29,146
-124 Reduced 0.91%
13,458 $2.32 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $42,679 - $69,648
189 Added 1.41%
13,582 $3.45 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $1.05 Million - $2.29 Million
4,729 Added 54.58%
13,393 $5.15 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $24,293 - $43,941
187 Added 2.21%
8,664 $2.04 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $17,141 - $29,198
157 Added 1.89%
8,477 $1.11 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $42,665 - $110,239
649 Added 8.46%
8,320 $869,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $416,842 - $727,594
7,671 New
7,671 $543,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.